Coronavirus (COVID-19) – Use of Lagevrio (molnupiravir) in residential aged care

This fact sheet outlines the key considerations of introducing Lagevrio (molnupiravir) into residential aged care clinical practices.

Coronavirus (COVID-19) – Use of Lagevrio (molnupiravir) in residential aged care

About this resource

Publication date:
Publication type:
Fact sheet
Audience:
General public
Language:
English